A rapid HPLC method for the determination of losartan in human plasma using a monolithic column

Arzneimittel-Forschung/Drug Research

Volumn 55, Issue 10, 2005, Pages 569-572

  Zarghi, Afshin ^a   Foroutan, Seyyed Mohsen ^a   Shafaati, Alireza ^a   Khoddam, Arash ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Noor Research and Educational Institute   (Iran)

Author keywords

Angiotensin II receptor antagonist; CAS 12450 98 8; Losartan, determination in plasma, HPLC method, metabolite

Indexed keywords

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ACETONITRILE; ANGIOTENSIN RECEPTOR ANTAGONIST; DISODIUM HYDROGEN PHOSPHATE; DRUG METABOLITE; LOSARTAN; METHANOL; THIORIDAZINE;

ACCURACY; ARTICLE; BIOEQUIVALENCE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ISOLATION; DRUG MONITORING; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; LINEAR REGRESSION ANALYSIS; NORMAL HUMAN; PH; PLASMA; QUANTITATIVE ANALYSIS; REPRODUCIBILITY;

EID: 27544467160     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296906     Document Type: Article

References (12)

1. Csajka, C., Buclin, T., Brunner, H. R. et al., Pharmacokinetic- pharmacodynamic profile of angiotensin II receptor antagonists. Clin. Pharmacokinet. 32, 1 (1997)
2. Klotz, U., Pharmacological comparison of the statins. Arzneim.-Forsch./Drug Res. 53, 605 (2003)
3. Lo, M. W., Goldberg, M. R., McCrea, J. B. et al., Pharmacokinetic- pharmacodynemic relations of losartan and EXP3174 in humans. Clin. Pharmacol. Ther. 58, 641 (1995)
4. Munafo, A., Christen, Y., Nussberger, J. et al., Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. Clin. Pharmacol. Ther. 51, 513 (1992)
5. Furtek, C. I., Lo, M. W., Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography. J. Chromatogr. (Biomed. Appl.). 573, 295 (1992)
6. Ritter, M. A., Furtek, C. I., Lo, M. W., An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with florescence detection. J. Pharm. Biomed. Anal. 15, 1021 (1997)
7. Soldner, A., Spahn-Langguth, H., Mutschler, E., HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP3174 in biological material of humans and rats. J. Pharm. Biomed. Anal. 16, 863 (1998)
8. Yeung, P. K. F., Jamieson, A., Smith, G. J. et al., Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection. Int. J. Pharm. 204, 17 (2000)
9. Gonzalez, L., Lopez., J. A., Alonso, R. M. et al., Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection. J. Chromatogr A 949, 49 (2002)
10. Iwasa, T., Takano, T., Hara, K. et al., Method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma by liquid chromatography-electrspray ionization tandem mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 734, 325 (1999)
11. Polinko, M., Riffel, K., Song, H. et al., Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry. J. Pharm. Biomed. Anal. 33, 73 (2003)
12. Ohtawa, M., Takayama, F., Saitoh, K. et al., Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans. Br. J. Clin. Pharmacol. 35, 290 (1993)